Upregulation of MiR-122 via Trichostatin A Treatments in Hepatocyte-like Cells Derived from Mesenchymal Stem Cells

Chemical Biology and Drug Design

Volumn 87, Issue 2, 2016, Pages 296-305

  Alizadeh, Effat ^a   Eslaminejad, MohamadReza Baghaban ^b   Akbarzadeh, Abolfazl ^a   Sadeghi, Zohre ^a   Abasi, Mozghan ^a   Herizchi, Roya ^a   Zarghami, Nosratollah ^a,c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

hepatocyte like cells; HNF4a; HNF6; mesenchymal stem cells; miR 122; trichostatin A; fetoprotein

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; DIMETHYL SULFOXIDE; EPIDERMAL GROWTH FACTOR; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HEPATOCYTE NUCLEAR FACTOR 6; MICRORNA 122; ONCOSTATIN M; SCATTER FACTOR; TRICHOSTATIN A; HEPATOCYTE NUCLEAR FACTOR 4; HNF4A PROTEIN, HUMAN; HYDROXAMIC ACID; MICRORNA;

ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER CELL; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; UPREGULATION; UREA CYCLE; CELL CULTURE; CELL LINEAGE; CYTOLOGY; DRUG EFFECTS; MESENCHYMAL STROMA CELL; METABOLISM;

ALPHA-FETOPROTEINS; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; DOWN-REGULATION; HEPATOCYTE NUCLEAR FACTOR 4; HEPATOCYTE NUCLEAR FACTOR 6; HEPATOCYTES; HUMANS; HYDROXAMIC ACIDS; MESENCHYMAL STROMAL CELLS; MICRORNAS; UP-REGULATION;

EID: 84951030327     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/cbdd.12664     Document Type: Article

References (45)

1. Chen Y., Zhou H., Sarver A.L., Zeng Y., Roy-Chowdhury J., Steer C.J., Sahin M.B., (2010) Hepatic differentiation of liver-derived progenitor cells and their characterization by microRNA analysis. Liver Transpl; 16: 1086-1097.
2. Haridass D., Narain N., Ott M., (2008) Hepatocyte transplantation: waiting for stem cells. Curr Opin Organ Transplant; 13: 627-632.
3. Moore J.K., Stutchfield B.M., Forbes S.J., (2014) Systematic review: the effects of autologous stem cell therapy for patients with liver disease. Aliment Pharmacol Ther; 39: 673-685.
4. Zhou W.L.M.C., Zhu L., Hay D.C., (2012) Stem cell differentiation and human liver disease. World J Gastroenterol; 18: 2018-2025.
5. Puglisi M.A., Tesori V., Lattanzi W., Piscaglia A.C., Gasbarrini G.B., D'Ugo D.M., Gasbarrini A., (2011) Therapeutic implications of mesenchymal stem cells in liver injury. J Biomed Biotechnol; 2011: 860578.
6. Ong S.Y., Dai H., Leong K.W., (2006) Inducing hepatic differentiation of human mesenchymal stem cells in pellet culture. Biomaterials; 27: 4087-4097.
7. Alizadeh E., Akbarzadeh A., Eslaminejad M.B., Barzegar A., Hashemzadeh S., Nejati-Koshki K., Zarghami N., (2014) Up-regulation of liver enriched transcription factors (HNF4a and HNF6) and liver specific microRNA (miR-122) by inhibition of let-7b in mesenchymal stem cells. Chem Biol Drug Des; 85: 268-279.
8. Iorio M.V., Piovan C., Croce C.M., (2010) Interplay between microRNAs and the epigenetic machinery: an intricate network. Biochim Biophys Acta; 1799: 694-701.
9. Sadeghi Z., Nejati-koshki K., Akbarzadeh A., Movasaghpour A., Alizadeh E., Zahra Davoudi H., Dariushnejad Nosratollah Z., (2014) Trichostatin A-induced Apoptosis is mediated by Krüppel-like factor 4 in ovarian and lung cancer. Asian Pac J Cancer Prev; 15: 6581-6586.
10. Han B., Li J., Li Z., Guo L., Wang S., Liu P., Wu Y., (2013) Trichostatin A stabilizes the expression of pluripotent genes in human mesenchymal stem cells during ex vivo expansion. PLoS ONE; 8: e81781.
11. Jody C., Chuang A.P.A.J., (2007) Epigenetics and microRNAs. Pediatr Res; 61: 24-29.
12. Chang J., Nicolas E., Marks D., Sander C., Lerro A., Buendia M.A., Xu C., Mason W.S., Moloshok T., Bort R., Zaret K.S., Taylor J.M., (2004) miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol; 1: 106-113.
13. Esau C., (2008) Inhibition of microRNA with antisense oligonucleotides. Methods; 44: 55-60.
14. Krutzfeldt J., Rajewsky N., Braich R., Rajeev K.G., Tuschl T., Manoharan M., Stoffel M., (2005) Silencing of microRNAs in vivo with 'antagomirs'. Nature; 438: 685-689.
15. Lagos-Quintana M., Rauhut R., Yalcin A., Meyer J., Lendeckel W., Tuschl T., (2002) Identification of tissue-specific microRNAs from mouse. Curr Biol; 12: 735-739.
16. Cui L., Shi Y., Zhou X., Wang X., Wang J., Lan Y., Wang M., Zheng L., Li H., Wu Q., Zhang J., Fan D., Han Y., (2013) A set of microRNAs mediate direct conversion of human umbilical cord lining-derived mesenchymal stem cells into hepatocytes. Cell Death Dis; 4: e918.
17. Deng X.G., Qiu R.L., Wu Y.H., Li Z.X., Xie P., Zhang J., Zhou J.J., Zeng L.X., Tang J., Maharjan A., Deng J.M., (2014) Overexpression of miR-122 promotes the hepatic differentiation and maturation of mouse ESCs through a miR-122/FoxA1/HNF4a-positive feedback loop. Liver Int; 34: 281-295.
18. Doddapaneni R., Chawla Y.K., Das A., Kalra J.K., Ghosh S., Chakraborti A., (2013) Overexpression of microRNA-122 enhances in vitro hepatic differentiation of fetal liver-derived stem/progenitor cells. J Cell Biochem; 114: 1575-1583.
19. Sood P., Krek A., Zavolan M., Macino G., Rajewsky N., (2006) Cell-type-specific signatures of microRNAs on target mRNA expression. Proc Natl Acad Sci USA; 103: 2746-2751.
20. Ross S.A., Davis C.D., (2011) MicroRNA, nutrition, and cancer prevention. Adv Nutr; 2: 472-485.
21. Aurich H., Sgodda M., Kaltwasser P., Vetter M., Weise A., Liehr T., Brulport M., Hengstler J.G., Dollinger M.M., Fleig W.E., Christ B., (2009) Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Gut; 58: 570-581.
22. Seo M.J., Suh S.Y., Bae Y.C., Jung J.S., (2005) Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. Biochem Biophys Res Commun; 328: 258-264.
23. Cui L., Zhou X., Li J., Wang L., Wang J., Li Q., Chu J., Zheng L., Wu Q., Han Z., Shi Y., Han Y., Fan D., (2012) Dynamic microRNA profiles of hepatic differentiated human umbilical cord lining-derived mesenchymal stem cells. PLoS ONE; 7: e44737.
24. Alizadeh E., Zarghami N., Eslaminejad M.B., Akbarzadeh A., Barzegar A., Mohammadi S.A., (2014) The effect of dimethyl sulfoxide on hepatic differentiation of mesenchymal stem cells. Artif Cells Nanomed Biotechnol; 30: 1-8.
25. Snykers S., Vanhaecke T., De Becker A., Papeleu P., Vinken M., Van Riet I., Rogiers V., (2007) Chromatin remodeling agent trichostatin A: a key-factor in the hepatic differentiation of human mesenchymal stem cells derived of adult bone marrow. BMC Dev Biol; 7: 24.
26. Pournasr B., Mohamadnejad M., Bagheri M., Aghdami N., Shahsavani M., Malekzadeh R., Baharvand H., (2011) In vitro differentiation of human bone marrow mesenchymal stem cells into hepatocyte-like cells. Arch Iran Med; 14: 244-249.
27. Puglisi M.A., Saulnier N., Piscaglia A.C., Tondi P., Agnes S., Gasbarrini A., (2011) Adipose tissue-derived mesenchymal stem cells and hepatic differentiation: old concepts and future perspectives. Eur Rev Med Pharmacol Sci; 15: 355-364.
28. Talens-Visconti R., Bonora A., Jover R., Mirabet V., Carbonell F., Castell J.V., Gomez-Lechon M.J., (2006) Hepatogenic differentiation of human mesenchymal stem cells from adipose tissue in comparison with bone marrow mesenchymal stem cells. World J Gastroenterol; 12: 5834-5845.
29. Davoodian N., Lotfi A.S., Soleimani M., Mowla S.J., (2014) MicroRNA-122 overexpression promotes hepatic differentiation of human adipose tissue-derived stem cells. J Cell Biochem; 115: 1582-1593.
30. Vacanti J.P., Kulig K,. (2014) Liver cell therapy and tissue engineering for transplantation. Semin Pediatr Surg; 23: 150-155.
31. Yamashita Y., Shimada M., Harimoto N., Rikimaru T., Shirabe K., Tanaka S., Sugimachi K., (2003) Histone deacetylase inhibitor trichostatin A induces cell-cycle arrest/apoptosis and hepatocyte differentiation in human hepatoma cells. Int J Cancer; 103: 572-576.
32. Snykers S., De K.J., Tamara V., Rogiers V., (2011) Hepatic differentiation of mesenchymal stem cells: in vitro strategies. Methods Mol Biol; 698: 305-314.
33. Yamamoto Y., Banas A., Murata S., Ishikawa M., Lim C.R., Teratani T., Hatada I., Matsubara K., Kato T., Ochiya T., (2008) A comparative analysis of the transcriptome and signal pathways in hepatic differentiation of human adipose mesenchymal stem cells. FEBS J; 275: 1260-1273.
34. Saulnier N., Piscaglia A.C., Puglisi M.A., Barba M., Arena V., Pani G., Alfieri S., Gasbarrini A., (2010) Molecular mechanisms underlying human adipose tissue-derived stromal cells differentiation into a hepatocyte-like phenotype. Dig Liver Dis; 42: 895-901.
35. Kim Y.J., Bae S.W., Yu S.S., Bae Y.C., Jung J.S., (2009) miR-196a regulates proliferation and osteogenic differentiation in mesenchymal stem cells derived from human adipose tissue. J Bone Miner Res; 24: 816-825.
36. Kojima K., Takata A., Vadnais C., Otsuka M., Yoshikawa T., Akanuma M., Kondo Y., et al,. (2011) MicroRNA122 is a key regulator of alpha-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma. Nat Commun; 2: 338.
37. Spooner B.S., Guikema J.A., Barnes G., (1990) Binding of alpha-fetoprotein by immobilized monoclonal antibodies during episodes of zero-gravity obtained by parabolic flight. Aviat Space Environ Med; 61: 725-728.
38. Giannini E.G., Sammito G., Farinati F., Ciccarese F., Pecorelli A., Rapaccini G.L., Di Marco M., et al,. (2014) Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: Implications for its clinical use. Cancer; 120: 2150-2157.
39. Hu J., Xu Y., Hao J., Wang S., Li C., Meng S., (2012) MiR-122 in hepatic function and liver diseases. Protein Cell; 3: 364-371.
40. Jung C.J., Iyengar S., Blahnik K.R., Ajuha T.P., Jiang J.X., Farnham P.J., Zern M., (2011) Epigenetic modulation of miR-122 facilitates human embryonic stem cell self-renewal and hepatocellular carcinoma proliferation. PLoS ONE; 6: e27740.
41. Bolleyn J., Fraczek J., Vinken M., Lizarraga D., Gaj S., van Delft J.H., Rogiers V., Vanhaecke T., (2011) Effect of trichostatin A on miRNA expression in cultures of primary rat hepatocytes. Toxicol In vitro; 25: 1173-1182.
42. Sato A., Saito Y., Sugiyama K., Sakasegawa N., Muramatsu T., Fukuda S., Yoneya M., Kimura M., Ebinuma H., Hibi T., Ikeda M., Kato N., Saito H., (2013) Suppressive effect of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) on hepatitis C virus replication. J Cell Biochem; 114: 1987-1996.
43. Henkens T., Papeleu P., Elaut G., Vinken M., Rogiers V., Vanhaecke T., (2007) Trichostatin A, a critical factor in maintaining the functional differentiation of primary cultured rat hepatocytes. Toxicol Appl Pharmacol; 218: 64-71.
44. Xu H., He J.-H., Xiao Z.-D., Zhang Q.-Q., Chen Y.-Q., Zhou H., Qu L.-H., (2010) Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development. Hepatology; 52: 1431-1442.
45. Laudadio I., Manfroid I., Achouri Y., Schmidt D., Wilson M.D., Cordi S., Thorrez L., Knoops L., Jacquemin P., Schuit F., Pierreux C.E., Odom D.T., Peers B., Lemaigre F.P., (2012) A feedback loop between the liver-enriched transcription factor network and Mir-122 controls hepatocyte differentiation. Gastroenterology; 142: 119-129.